Literature DB >> 23353902

Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats.

Milos Mitic1, Iva Simic, Jelena Djordjevic, Marija B Radojcic, Miroslav Adzic.   

Abstract

Chronic psychosocial isolation stress (CPSI) modulates glucocorticoid receptor (GR) functioning in Wistar male rat hippocampus (HIPPO) through alteration of nuclear GR phosphorylation and its upstream kinases signaling, which parallels animal depressive-like behavior. The current study investigated potential gender specificities regarding the effect of chronic therapy by an antidepressant fluoxetine (FLU) on GR signaling in HIPPO and depressive-like behavior in CPSI animals. FLU was administrated to female and male naïve or CPSI rats for 21 days and GR protein, its phosphorylation status and upstream kinases, as well as GR and BDNF mRNA were followed in HIPPO together with animal serum corticosterone (CORT) and depressive-like behavior. The results showed that CPSI increased immobility in males versus hyperactivity in females and disrupted nuclear pGR232-Cdk5 pathway and JNK signaling in a gender-specific way. In contrast, in both genders CPSI increased the nuclear levels of GR and pGR246 but decreased CORT and mRNA levels of GR and BDNF. Concomitant FLU normalized the depressive-like behavior and altered the nuclear pGR232-Cdk5 signaling in a gender-specific manner. In both females and males, FLU reversed the nuclear levels of GR and pGR246 without affecting CORT and GR mRNA levels. In contrast, FLU exhibited gender-specific effect on BDNF mRNA in CPSI animals, by increasing it in females, but not in males. In spite of normalization the total nuclear GR level upon FLU treatment in both gender, down-regulation of GR mRNA is possibly maintained through prevalence of pGR232 isoform only in males. The gender-specific alterations of pGR232-Cdk5 signaling and BDNF gene expression in HIPPO and normalization of depressive-like behavior upon FLU treatment distinguishes this signaling pathway as potential future antidepressant target for gender-specific therapy of stress related mood disorders.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353902     DOI: 10.1016/j.neuropharm.2012.12.012

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  Ovarian hormones modify anxiety behavior and glucocorticoid receptors after chronic social isolation stress.

Authors:  Dinah L Ramos-Ortolaza; Raura J Doreste-Mendez; John K Alvarado-Torres; Annelyn Torres-Reveron
Journal:  Behav Brain Res       Date:  2017-04-10       Impact factor: 3.332

Review 2.  Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants.

Authors:  Florian Duclot; Mohamed Kabbaj
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

3.  Fluoxetine signature on hippocampal MAPK signalling in sex-dependent manner.

Authors:  Milos Mitic; Iva Lukic; Natalija Bozovic; Jelena Djordjevic; Miroslav Adzic
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

4.  Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism.

Authors:  Christina R Tyler; Benjamin R Solomon; Adam L Ulibarri; Andrea M Allan
Journal:  Neurotoxicology       Date:  2014-06-18       Impact factor: 4.294

Review 5.  Pathophysiology of affective disorders: functional interaction of stress hormones and hippocampal excitation.

Authors:  M Adrienne McGinn; Amanda R Pahng
Journal:  J Neurophysiol       Date:  2016-05-11       Impact factor: 2.714

6.  Involvement of nitric oxide in improving stress-induced behavioural alteration by glatiramer acetate treatment in female BALB/c mice.

Authors:  Cecilia Gabriela Pascuan; Elias Hugo Simon; Ana María Genaro; María Laura Palumbo
Journal:  Psychopharmacology (Berl)       Date:  2014-11-07       Impact factor: 4.530

7.  Modulation of c-Jun N-terminal kinase signaling and specific glucocorticoid receptor phosphorylation in the treatment of major depression.

Authors:  Milica J Jovicic; Iva Lukic; Marija Radojcic; Miroslav Adzic; Nadja P Maric
Journal:  Med Hypotheses       Date:  2015-06-02       Impact factor: 1.538

8.  Experience and activity-dependent control of glucocorticoid receptors during the stress response in large-scale brain networks.

Authors:  Damien Huzard; Virginie Rappeneau; Onno C Meijer; Chadi Touma; Margarita Arango-Lievano; Michael J Garabedian; Freddy Jeanneteau
Journal:  Stress       Date:  2020-08-26       Impact factor: 3.493

9.  Disrupting monotony during social isolation stress prevents early development of anxiety and depression like traits in male rats.

Authors:  Saroj Kumar Das; Kalpana Barhwal; Sunil Kumar Hota; Mahendra Kumar Thakur; Ravi Bihari Srivastava
Journal:  BMC Neurosci       Date:  2015-02-14       Impact factor: 3.288

Review 10.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.